Modern Healthcare Technology Holdings (STU:M3L) ROCE %: -5.22% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Modern Healthcare Technology Holdings ROCE %?

Modern Healthcare Technology Holdings STU:M3L ROCE % is -5.22% as of Mar. 2026. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Modern Healthcare Technology Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was -5.22%.

Modern Healthcare Technology Holdings  (STU:M3L) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Modern Healthcare Technology Holdings ROCE % Related Terms

Modern Healthcare Technology Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Modern Healthcare Technology Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Healthcare Technology Holdings ROCE % Chart

Modern Healthcare Technology Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.60 -7.41 -1.56 0.62 1.42

Modern Healthcare Technology Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.38 -11.18 13.79 7.82 -5.22

Modern Healthcare Technology Holdings ROCE % Calculation

Modern Healthcare Technology Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=0.352/( ( (67.173 - 41.924) + (57.621 - 33.332) )/ 2 )
=0.352/( (25.249+24.289)/ 2 )
=0.352/24.769
=1.42 %

Modern Healthcare Technology Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=-1.302/( ( (61.486 - 35.912) + (57.621 - 33.332) )/ 2 )
=-1.302/( ( 25.574 + 24.289 )/ 2 )
=-1.302/24.9315
=-5.22 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -5.22% mean?
Modern Healthcare Technology Holdings (STU:M3L) has a ROCE % of -5.22% as of Mar. 2026.
Is Modern Healthcare Technology Holdings' ROCE % too high?
Modern Healthcare Technology Holdings' current ROCE % is -5.22%.
How does Modern Healthcare Technology Holdings' ROCE % compare to ROL and SCI?
Modern Healthcare Technology Holdings' ROCE % of -5.22% can be compared against companies in the Personal Services industry. The industry median ROCE % is 6.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Personal Services company?
The median ROCE % among Personal Services companies is 6.00, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median ROCE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Healthcare Technology Holdings's current ROCE % is -5.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Healthcare Technology Holdings stock overvalued right now?
Based on GuruFocus' analysis, Modern Healthcare Technology Holdings (STU:M3L) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading 40% below its estimated fair value. The current ROCE % is -5.22%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Modern Healthcare Technology Holdings (STU:M3L), the current ROCE % is -5.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Healthcare Technology Holdings Business Description

Other Exchanges 00919:Hong Kong
Address 9 Kai Cheung Road, Workshops Nos. 66-68, 6th Floor, Sino Industrial Plaza, Kowloon Bay, Kowloon, Hong Kong, HKG
Modern Healthcare Technology Holdings Ltd is an investment holding company. The company's operating segment includes Beauty and wellness services and Skincare and wellness products. The company generates maximum revenue from Beauty and wellness services segment. The Beauty and Wellness Services segment of the company is engaged in the provision of beauty and wellness services which provides a wide range of health and beauty services, covering skin care, slimming, massage, spa, hair care, manicure, hair removal, makeup, joint care, and privacy care. Geographically, the company derives the maximum of its revenue from Hong Kong and has a presence in Singapore; China, and Australia.